Tirzepatide 10mg arrives as a lyophilised powder in a sealed glass vial. It carries a batch code. You handle it exactly like the Retatrutide range it sits alongside.
About the compound
Tirzepatide acts at two receptors, GIP and GLP-1. Because it covers two pathways rather than one, it served as the reference compound in metabolic research before Retatrutide arrived. Researchers still study it widely. ClinicalTrials.gov carries the trial documentation.
Purity runs at 99 percent or higher. Furthermore, the QR code on each label points to that individual batch. It returns the compound, the vial size and the batch number, and you need no account. The whole check takes seconds.
Tirzepatide 10mg compared with Retatrutide
Receptor coverage marks the practical difference. Tirzepatide acts at two sites while Retatrutide acts at three. So most groups run the two as separate arms rather than substitutes. In addition, the reconstitution, storage and handling match exactly. A laboratory already working with one can move to the other without changing procedure.
If you want both in a single vial, the Retatrutide Tirzepatide blend combines them at a fixed ratio. For longer runs, the 30mg vial drops the per milligram figure considerably. It also cuts the number of reconstitutions.
We dispatch orders placed before 3pm that same afternoon, seven days a week. Bangkok addresses receive the vial the same day. The rest of Thailand takes 1 to 3 days, tracked. Tracking reaches your inbox on dispatch.
Storage
A sealed lyophilised vial stays stable at room temperature and needs no cold chain in transit. After reconstitution, however, refrigerate between 2 and 8 degrees Celsius and keep it away from direct light. You order bacteriostatic water separately, so the volume matches your protocol. The reconstitution calculator works out the fill point and the doses per vial.
For laboratory research use only. Not for human consumption.
